Neoadjuvant Chemotherapy Followed by Cytoreductive Surgery and HIPEC Improves Survival in Peritoneal Metastatic Gastric Cancer.

Selin Akturk Esen,Yigit Mehmet Ozgun,Denizcan Hasturk,Gokhan Ucar,Erdal Birol Bostanci,Mehmet Sendur,Dogan Uncu

Oncology（2023）

引用 0|浏览2

暂无评分

摘要

As a result, CRS+HIPEC significantly improves survival in PMGC patients. With experienced surgical centres and appropriate patient selection, the life expectancy of patients with PM can be extended.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要